Local News

FDA Approves GSK Asthma Drug for Younger Children

Posted March 23, 2006 3:26 a.m. EST

— The U.S. Food and Drug Administration has granted its approval for the winder use of the


asthma drug known as Flovent HFA.

Flovent can now be prescribed for children ages 4 to 11, GSK said Thursday.

Some 3.6 million children ages 5-11 have asthma, according to federal health statistics cited by GSK.

Flovent was approved for use for patients ages 12 and older in 2004.